Clinical Trial Update: Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of PGN-EDODM1 in participants with Myotonic Dystrophy Type 1; the trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• PGN-EDODM1

Snippet

Sponsor: PepGen Inc | Conditions: Myotonic Dystrophy 1 | Phase 1 | Status: COMPLETED